These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7678453)

  • 1. A phase 2 study of cisplatin in patients with hepatocellular carcinoma.
    Okada S; Okazaki N; Nose H; Shimada Y; Yoshimori M; Aoki K
    Oncology; 1993; 50(1):22-6. PubMed ID: 7678453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
    Aogi K; Sawamura A; Funakoshi M; Toge T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
    Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH
    Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma.
    Shibata J; Fujiyama S; Sato T; Kishimoto S; Fukushima S; Nakano M
    Cancer; 1989 Oct; 64(8):1586-94. PubMed ID: 2477131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment for advanced hepatocellular carcinoma by hepatic arterial infusion of CDDP powder as second-line chemotherapy].
    Gen Y; Kimura H; Akitake R; Sakai A; Fukui A; Takao T; Ikezawa S; Masuda A; Takashima H; Funatsu E; Nakamura H; Okuyama Y; Arai M; Yagi N; Kutsumi H; Fujimoto S; Takeuchi Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):505-8. PubMed ID: 16612162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
    Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
    Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
    Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
    Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
    Leung TW; Patt YZ; Lau WY; Ho SK; Yu SC; Chan AT; Mok TS; Yeo W; Liew CT; Leung NW; Tang AM; Johnson PJ
    Clin Cancer Res; 1999 Jul; 5(7):1676-81. PubMed ID: 10430068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
    Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
    Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma].
    Aoki Y; Hirai K; Yamashita K; Noguchi H; Sakai T; Majima Y; Tanikawa K; Inoue H; Okano Y; Hitoshi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3066-9. PubMed ID: 2476969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
    Melia WM; Westaby D; Williams R
    Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
    Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
    Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
    J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin and cisplatin for hepatoblastoma.
    Quinn JJ; Altman AJ; Robinson HT; Cooke RW; Hight DW; Foster JH
    Cancer; 1985 Oct; 56(8):1926-9. PubMed ID: 2411381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I Study of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma.
    Ishizaki M; Kaibori M; Matsui K; Ikeda H; Yoshida K; Okazaki K; Kariya S; Tanigawa N; Nakatake R; Matsushima H; Sakaguchi T; Kon M
    Cancer Invest; 2017 Apr; 35(4):271-276. PubMed ID: 28272913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.